Results released Tuesday from an early study of an autoimmune disease drug from Roivant Sciences’ Immunovant showed the treatment could reduce the levels of a
Tag - drug development
Travere Therapeutics said Thursday that a study meant to confirm the benefit of its newly approved drug for a rare kidney disorder narrowly failed. In the
A diagnosis of ALS has long been seen as a death sentence. But in recent years, progress in the world of ALS research and drug development has come to embody a
Swiss drugmaker Novartis’ research and development hub has a new name — and a new guiding strategy. The hub, which is headquartered in Cambridge, Mass., and
The release of Novo Nordisk’s latest earnings report on Thursday provided a chance for executives to tout their major win this week — outcomes from a large
Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression of an autoimmune nerve disorder that
When Timothy Yu developed milasen, a custom drug for a young girl named Mila with Batten disease, he ignited a spark in the field of personalized medicine
FRANKFURT, Germany — Protagonist Therapeutics has run into some speed bumps as it’s developed its medicine for a rare blood cancer characterized by the
DALLAS — A top Food and Drug Administration official said Monday that the agency needs to start using accelerated approval, a much-debated path commonly used
Maria Fabrizio for STAT This is the first article in a series about new obesity drugs that are transforming patients’ lives, dividing medical experts, and
